
APPROVED The figure should consist of four panels (A–D) arranged sequentially: A: EPO receptor in complex with EPO. B: Insulin receptor in complex with insulin. C: Insulin receptor in complex with IR‑TM peptides. D: Growth hormone receptor in complex with GH. Arrows should indicate ligand/peptide binding and subsequent receptor dimerization/activation. A bottom strip should depict "JAK2: Inactive" versus "JAK2: Active" (or equivalent wording). The overall message is that the IR‑TM peptide activates the IR in a manner analogous to JAK2.
Three-stage progressive research: from basic mechanism analy...